The closing price of Invesco Ltd (NYSE: IVZ) was $15.87 for the day, down -6.32% from the previous closing price of $16.94. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 6261017 shares were traded.
Ratios:
Our analysis of IVZ’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.25. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on January 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $21.
On December 14, 2023, Keefe Bruyette Upgraded its rating to Outperform which previously was Mkt Perform and also upped its target price recommendation from $15.50 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 02 ’23 when Invesco Realty, Inc. bought 796,323 shares for $25.12 per share. The transaction valued at 20,000,000 led to the insider holds 1,052,487 shares of the business.
Invesco Realty, Inc. bought 2,800,000 shares of IVZ for $70,000,000 on Sep 05 ’23. The 10% Owner now owns 853,400 shares after completing the transaction at $25.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 7.13B and an Enterprise Value of 18.26B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at 3.19 whereas that against EBITDA is 16.14.
Stock Price History:
Over the past 52 weeks, IVZ has reached a high of $18.71, while it has fallen to a 52-week low of $12.48. The 50-Day Moving Average of the stock is 15.85, while the 200-Day Moving Average is calculated to be 15.61.
Shares Statistics:
IVZ traded an average of 4.72M shares per day over the past three months and 4.55M shares per day over the past ten days. A total of 449.50M shares are outstanding, with a floating share count of 441.75M. Insiders hold about 1.66% of the company’s shares, while institutions hold 84.97% stake in the company. Shares short for IVZ as of Mar 15, 2024 were 8.04M with a Short Ratio of 2.20, compared to 7.75M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.79% and a Short% of Float of 2.61%.
Dividends & Splits
With its trailing 12-month dividend rate of 0.80, IVZ has a forward annual dividend rate of 0.80. Against a Trailing Annual Dividend Yield of 4.72%, it implies a Forward Annual Dividend Yield of 4.86%. The stock’s 5-year Average Dividend Yield is 5.41.
Earnings Estimates
The firm’s stock currently is rated by 13 analysts. On average, analysts expect EPS of $0.39 for the current quarter, with a high estimate of $0.41 and a low estimate of $0.34, while EPS last year was $0.38. The consensus estimate for the next quarter is $0.42, with high estimates of $0.45 and low estimates of $0.35.
Analysts are recommending an EPS of between $1.81 and $1.5 for the fiscal current year, implying an average EPS of $1.72. EPS for the following year is $1.92, with 14 analysts recommending between $2.07 and $1.65.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 9 analysts. It ranges from a high estimate of $1.12B to a low estimate of $1.07B. As of the current estimate, Invesco Ltd’s year-ago sales were $1.08B, an estimated increase of 1.40% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $1.11B, an increase of 2.00% over than the figure of $1.40% in the same quarter last year. There is a high estimate of $1.16B for the next quarter, whereas the lowest estimate is $1.08B.
A total of 9 analysts have provided revenue estimates for IVZ’s current fiscal year. The highest revenue estimate was $4.65B, while the lowest revenue estimate was $4.38B, resulting in an average revenue estimate of $4.49B. In the same quarter a year ago, actual revenue was $4.31B, up 4.10% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $4.69B in the next fiscal year. The high estimate is $4.88B and the low estimate is $4.55B. The average revenue growth estimate for next year is up 4.40% from the average revenue estimate for this year.
